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Abstract
Background: Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are capable of repairing wounded lung
epithelial cells by donating cytoplasmic material and mitochondria. Recently, we characterized two populations of
human lung-derived mesenchymal stromal cells isolated from digested parenchymal lung tissue (LT-MSCs) from
healthy individuals or from lung transplant recipients’ bronchoalveolar lavage fluid (BAL-MSCs). The aim of this
study was to determine whether LT-MSCs and BAL-MSCs are also capable of donating cytoplasmic content and
mitochondria to lung epithelial cells.
Methods: Cytoplasmic and mitochondrial transfer was assessed by co-culturing BEAS2B epithelial cells with
Calcein AM or Mitotracker Green FM-labelled MSCs. Transfer was then measured by flow cytometry and validated
by fluorescent microscopy. Molecular inhibitors were used to determine the contribution of microtubules/tunnelling
nanotubes (TNTs, cytochalasin D), gap junctions (carbenoxolone), connexin-43 (gap26) and microvesicles (dynasore).
Results: F-actin microtubules/TNTs extending from BM-MSCs, LT-MSCs and BAL-MSCs to bronchial epithelial cells
formed within 45 minutes of co-culturing cells. Each MSC population transferred a similar volume of cytoplasmic
content to epithelial cells. Inhibiting microtubule/TNTs, gap junction formation and microvesicle endocytosis
abrogated the transfer of cytoplasmic material from BM-MSCs, LT-MSCs and BAL-MSCs to epithelial cells. In
contrast, blocking connexin-43 gap junction formation had no effect on cytoplasmic transfer. All MSC populations
donated mitochondria to bronchial epithelial cells with similar efficiency. Mitochondrial transfer was reduced in
all co-cultures after microtubule/TNT or endocytosis inhibition. Gap junction formation inhibition reduced
mitochondrial transfer in BM-MSC and BAL-MSC co-cultures but had no effect on transfer in LT-MSC co-cultures.
Connexin-43 inhibition did not impact mitochondrial transfer. Finally, bronchial epithelial cells were incapable of
donating cytoplasmic content or mitochondria to any MSC population.
Conclusion: Similar to their bone marrow counterparts, LT-MSCs and BAL-MSCs can donate cytoplasmic content
and mitochondria to bronchial epithelial cells via multiple mechanisms. Given that BM-MSCs utilize these mechanisms to
mediate the repair of damaged bronchial epithelial cells, both LT-MSCs and BAL-MSCs will probably function similarly.
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Background
Recent studies suggest that adult stem cells reside within
niches where they coordinate organ homeostasis and re-
pair after injury. In the bone marrow, mesenchymal stro-
mal cells (MSCs) and haematopoietic stem cells (HSCs)
reside proximal to adrenergic nerve fibres to form the
HSC niche [1]. Bone marrow-derived MSCs (BM-MSCs)
are an essential component of this structure, forming
gap junctions with HSCs and expressing HSC mainten-
ance genes which directly contribute to the HSC volume
and capacity to mobilize to extramedullary sites during
haematopoiesis [1]. Emerging evidence suggests that the
function of MSCs within stem cell niches, irrespective of
organ, is to provide support for and coordinate the be-
haviour of parenchymal progenitor cells [1–4]. In order
to accomplish this, BM-MSCs must be able to effectively
communicate and interact with their target cells. Known
mechanisms already characterized for BM-MSCs include
microtubules [5], tunnelling nanotubes (TNTs) [3, 6–8],
gap junctions [9], microvesicles [9–12] and exosomes
[13, 14]. While the transferred material is yet to be fully
defined, it is known to include growth factors [1, 7],
microRNA [14], immuno-modulatory molecules [15–17]
and mitochondria [5, 6, 8, 9]. Notably, mitochondrial
transfer is emerging as an important mechanism by
which MSCs can stabilize or enhance the bioenergetic
potential of target cells, which includes alveolar epi-
thelial cells [9] and alveolar macrophages [18]. These
mechanisms are thought to contribute to the thera-
peutic benefit of MSCs by enhancing epithelial prolif-
eration [5, 9], modulating T-lymphocyte proliferation
[19, 20] and inducing the polarization of macrophages
towards the M2 phenotype [18, 21, 22]. As such, MSCs
have been demonstrated to promote tissue homeosta-
sis and tissue repair in multiple models of lung injury
including heat shock [5, 23], cigarette smoke-mediated
wounding [6], acute lung injury [8, 9], experimental
asthma [8, 24, 25] and bleomycin-induced pulmonary
fibrosis [26, 27]. Despite this knowledge, whether these
modes of behaviour exist in MSC populations which
reside endogenously within the human lung remains
to be elucidated.
The relationship between MSCs and parenchymal
progenitor cells is yet to be fully described in the hu-
man lung, but is probably analogous to that of the
bone marrow. We suspected that human lung MSCs
promote tissue homeostasis and repair by donating
cytoplasmic material and mitochondria to parenchy-
mal cells such as bronchial epithelium. Evidence to
support this hypothesis comes from murine studies
which demonstrate that lung-derived MSCs produce
growth factors such as fibroblast growth factor-10 and
hepatocyte growth factor, which promote the prolifera-
tion and propagation of lung epithelial progenitor cells
into complex airway and alveolar structures [2, 28].
Recently, we described two populations of human lung
MSCs isolated from digested parenchymal lung tissue
(LT-MSCs) from healthy individuals or from lung
transplant recipients’ bronchoalveolar lavage fluid
(BAL-MSCs) [30]. The aim of this study was to test
the hypothesis that, like their bone marrow counterparts,
human lung-derived MSCs donate cytoplasmic content
and mitochondria to human bronchial epithelial cells, in
vitro, and to characterize the underlying mechanisms.
Method
Cell lines and ethics
Human BM-MSCs were kindly donated by Cell and Tissue
Therapies, WA, Australia. BEAS2B epithelial cell lines were
purchased from American Type Tissue Culture Collection.
LT-MSC isolation
Parenchymal lung tissue was obtained from patients
undergoing a blebectomy to treat recurrent pneumo-
thorax. Samples of macroscopically normal lung were
mechanically digested into 1 mm3 pieces and seeded
onto plastic culture dishes at a density of 1 g per dish
(10 cm diameter). Cells were maintained in Dulbecco’s
modified Eagle medium (DMEM; Gibco), supplemented
with 10 % fetal calf serum and penicillin/streptomycin/
glutamine (Gibco). Between 7 and 14 days after seed-
ing, colony-forming units comprised of LT-MSCs were
observable. MSC colonies were isolated and transferred
to individual flasks where they were allowed to clonally
expand up to 60–80 % confluence, after which they
were cryopreserved in liquid nitrogen. All cells used
were between passages 2 and 4 and were preserved in
liquid nitrogen prior to use.
BAL-MSC isolation
We and others have reported previously that BAL-MSCs
are rarely isolated from healthy individuals [29, 30].
Bronchoalveolar lavage (BAL) fluid was therefore col-
lected from lung transplant recipients undergoing a
post-transplant bronchoscopy. BAL was performed by
wedging the bronchoscope in the middle lobe or lingula,
infusing 100 ml of 0.9 % saline via the working channel
and aspirating the effluent. BAL samples were immedi-
ately centrifuged and seeded into six-well plates at a
density of (0.3-0.4) × 106 cells/well. Colony-forming units
comprised of BAL-MSCs were observable within 14–21
days after seeding. Cells were expanded and maintained
as already detailed.
MSC characterization
As described previously [29, 31], BAL-MSCs and LT-MSCs
are classified as MSCs based on the diagnostic criteria out-
lined by The Internationally Society for Cellular Therapy
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[32] and transcriptional profiling [33]. Briefly, both
populations are plastic adherent, express the cell sur-
face proteins CD105, CD73 and CD90, and lack CD45
expression. Cells also have a demonstrable capacity for
osteoblast, chondroblast and adipocyte differentiation
[29, 30, 31]. Finally, both populations qualify as MSCs
according to transcriptional profiling [30, 33]. Add-
itionally, BAL-MSCs lack characteristic fibrocyte
markers and express a HLA serotype consistent with
that of the lung donor.
Cytoplasmic exchange and mitochondrial donation assays
BEAS2B lung epithelial cells were labelled with 5 μl of
DiD labelling solution (Life Technologies) for 20 minutes
at 37 °C. MSCs were labelled with 1 mM Calcein AM
(Life Technologies) for 35 minutes at 37 °C or 40 nM
Mitotracker Green (Life Technologies) for 20 minutes at
37 °C. Cells were cultured in 24-well sized plates pre-
coated with a solution of 0.1 mg/ml fibronectin (Sigma
Aldrich), 0.03 mg/ml bovine collagen type 1 (Worthing-
ton) and 0.01 mg/ml bovine serum albumin (Bovogen).
Then 3 × 104 BEAS2B cells were seeded and allowed to
adhere overnight, prior to the addition of 3 × 104 MSCs.
Cells were co-cultured for 4 hours in a 1:1 mixture of
basal epithelial growth medium (BEGM; Lonza) and
DMEM containing 10 % fetal calf serum. Cells were then
washed with phosphate-buffered saline (PBS) and de-
tached by incubating cells in 0.25 % trypsin (Gibco) for
5 minutes at 37 °C. Prior to flow cytometric assessment,
cellular viability was assessed using 4 % trypan blue exclu-
sion and light microscopy. Cellular viability was always
greater than 95 %. For transwell assays, all details are as
already listed except MSCs were seeded into 0.4 μM trans-
well inserts (MilliCell). Specific dye transfer was measured
by gating on DiDPos events, excluding doublets (forward
scatter width vs height) and measuring fluorescence in the
fluorescein channel (Additional file 1: Figure S1 and
Additional file 2: Figure S2). The mean fluorescent inten-
sity (MFI) is expressed as a ratio to unstained controls.
Flow cytometry was performed on a FACS CantoA (BD)
and data were analysed using FloJo (Tree Star). Each data
point shown in Figs. 2, 3, 4 and 5 represents the average
of two replicates.
Inhibitory compounds (or vehicle controls; Additional
file 3: Table S1) used to determine the mechanisms under-
lying cytoplasmic/mitochondrial transfer were added to
culture simultaneously with MSCs and remained in cul-
ture for the duration of the assay.
Fluorescent microscopy
Co-cultures were fixed with 4 % paraformaldehyde (BD),
permeabilized with 1 % Triton X (Scharlau) in PBS and
blocked for 1 hour in 1 % bovine serum albumin (Bovo-
gen). Co-cultured cells were stained with Phalloidin
(AbCam CytoPainter Kit) for 90 minutes for microtu-
bules/TNTs, as per the manufacturer’s instructions, and
α-cytokeratin-FITC (15 μG; Milltenyi) for epithelial cells,
washed with PBS and mounted in ProLong Gold (con-
taining DAPI; Life Technologies). Fluorescent labelling
was visualized using an Axiolmager Z1 microscope
(Zeiss) and Axiovision image acquisition software. For
live cell confocal microscopy, MSCs were labelled with
Mitotracker Green FM and BEAS2B cells with DiD, as
already described. Cells were seeded onto 10 mm diam-
eter glass-bottom culture dishes (Ibidi). Dishes were im-
aged at 37 °C at a rate of 1 image per 10 seconds using a
63× oil immersion lens, coupled with a 10× eyepiece
lens and a differential interference contrast filter using a
Leica TCS SP2 microscope.
Statistics
Statistical analysis was performed using Stata v11 (Stata-
Corp) with the Mann–Whitney U test or Wilcoxon
signed-rank test, as appropriate. All data are expressed
Fig. 1 BM-MSCs, LT-MSCs and BAL-MSCs connect with BEAS2B bronchial epithelial cells through F-actin containing microtubules. Representative
immunofluorescent images of (a) BM-MSCs, (b) LT-MSCs and (c) BAL-MSCs co-cultured with BEAS2B epithelial cells. Epithelial cells (green) were
labelled with cytokeratin and all cells were counterstained with phalloidin (F-actin, red). Cell nuclei were labelled with DAPI (blue). Images
shown at 630× magnification. White arrows depict microtubules connecting MSCs and epithelial cells
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as median and interquartile range unless otherwise stated.
Statistical significance was defined as p < 0.05.
Results
Patient demographics
Healthy parenchymal lung tissue was collected from 10
patients (six male) with a median age of 24.9 (21.7–
27.9) years. BAL-MSCs were collected from 14 lung
transplant recipients (10 male) with a median donor
age of 30 (28–54) years and median time post trans-
plant of 2.78 (0.27–4.48) years. Patient demographics
for BAL-MSCs are presented in Table 1.
BM-MSCs, LT-MSCs and BAL-MSCs connect with BEAS2B
epithelial cells via microtubules and TNTs
Microtubules and TNTs were first observed connecting
MSCs and BEAS2B epithelial cells after 45 minutes of
co-culturing cells. These projections stained strongly
with phalloidin indicating that they are comprised of F-
actin, consistent with previous reports for BM-MSCs
[8] (Fig. 1).
BM-MSCs, LT-MSCs and BAL-MSCs have a similar
efficiency for uni-directional cytoplasmic transfer to
BEAS2B epithelial cells
We aimed to determine whether the observed inter-
action between MSCs and epithelial populations medi-
ated the transfer of cytoplasmic material. Calcein AM
transfer from MSCs to epithelial cells was rapid and first
observed after 4 hours of co-culture, as shown by an in-
crease in BEAS2B cell Calcein AM fluorescence (Fig. 2)
and a corresponding decrease in MSC Calcein AM
fluorescence (Additional file 4: Figure S3A).
Cytoplasmic transfer occurred at a similar level for
all MSC populations (Fig. 2d). After co-culture with
BM-MSCs, the Calcein AM MFI in BEAS2B cells was
increased 223.5-fold (172.2–565.9, n = 14). Similarly,
BEAS2B Calcein AM MFI was increased 252.1-fold
Fig. 2 BM-MSCs, LT-MSCs and BAL-MSCs donate cytoplasmic contents to BEAS2B epithelial cells. Cytoplasmic transfer between mesenchymal
stromal cells (MSCs) and BEAS2B bronchial epithelial cells was measured by flow cytometry and immunofluorescence. a Representative flow
cytometry plot of transfer after MSCs were labelled with Calcein AM and co-cultured with BEAS2B cells for 4 hours. Blue line represents
co-cultured BEAS2B cells, red line represents unstained control. b To assess whether epithelial cells were capable of donating cytoplasmic
material to MSCs, BEAS2B cells were labelled with Calcein AM and co-cultured with MSCs for 4 h. Blue line represents co-cultured MSCs, red
line represents unstained control. c Representative flow cytometry plot of transfer after MSCs were labelled with Calcein AM and co-
cultured with BEAS2B cells within a transwell configuration. d Grouped data of cytoplasmic transfer by bone marrow-derived (BM-MSCs),
lung tissue-derived (LT-MSCs) and bronchoalveolar fluid-derived (BAL-MSCs) MSCs. Y axis represents the fold-change increase in Calcein AM
mean fluorescent intensity (MFI) of BEAS2B cells after co-culture with each respective MSC population. Horizontal bars represent median.
e–g Representative immunofluorescent images of cytoplasmic transfer by BM-MSCs (e), LT-MSCs (f) and BAL-MSCs (g). MSCs were pre-
labelled with Calcein AM (green) and co-cultured with BEAS2B epithelial cells labelled with DiD (red). BEAS2B cells containing MSC-derived
Calcein AM appear yellow/orange. Images shown at 630× magnification. Scale bars represent 10 μM
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(150.9–252.1, n = 9) after co-culture with LT-MSCs and
was increased 192.3-fold (156.9–513.4, n = 12) after co-
culture with BAL-MSCs. We did not observe Calcein
AM transfer when the cells were separated by transwell
culture (Fig. 2c). Finally, cytoplasmic transfer was uni-
directional and could not be observed to occur from
BEAS2B cells to any MSC population (Fig. 2b).
Cytoplasmic transfer from BM-MSCs, LT-MSCs and
BAL-MSCs to BEAS2B epithelial cells is mediated by
contact-dependent and contact-independent mechanisms
We next sought to characterize the mechanisms of
cytoplasmic transfer between MSCs and epithelial cells
(Fig. 3). In line with a previous report [9], we used the
dynamin inhibitor, Dynasore, to inhibit BEAS2B cells
endocytosing MSC-produced microvesicles. Endocyto-
sis inhibition reduced cytoplasmic transfer by 61.3 %
(58.7–64.1), 47.7 % (47.1–48.7) and 57.7 % (45.68–57.7)
in BM-MSC, LT-MSC and BAL-MSC co-cultures, re-
spectively (n = 6, p < 0.05 for all; Fig. 3). Blocking
microtubule/TNT formation using the actin polymerase
inhibitor cytochalasin D [34] reduced cytoplasmic
transfer by 43.0 % (31.7–44.3), 40.5 % (19.3–41.2) and
36.0 % (34.6–39.4) from BM-MSCs, LT-MSCs and
BAL-MSCs, respectively (n = 6, p < 0.05 for all). The
greatest reduction in cytoplasmic transfer was observed
using the non-specific gap junction blocker carbenoxo-
lone [35, 36] (Fig. 3). Cytoplasmic transfer from BM-
MSCs to BEAS2B cells was reduced by 90.8 % (88.9–
93.2, p < 0.05, n = 6) after carbenoxolone treatment.
Similarly, transfer was reduced by 85.0 % (79.4–87.5, p <
0.05, n = 6) and 88.5 % (85.6–90.9, p < 0.05, n = 6) in LT-
MSC and BAL-MSC co-cultures respectively. To de-
termine the contribution of connexin-43-dependent
gap junctions, which have previously been demon-
strated to mediate cytoplasmic transfer in murine
studies [9], we employed the inhibitor gap26 [37, 38].
Blocking connexin-43 did not prevent cytoplasmic trans-
fer with any MSC cell type.
BM-MSCs, LT-MSCs and BAL-MSCs share similar efficiency
for uni-directional mitochondrial transfer to BEAS2B
epithelial cells
BM-MSCs can promote the regeneration of damaged
lung epithelial cells through the donation of mitochon-
dria using similar mechanisms to those described for
cytoplasmic transfer [5, 9]. We found that all MSC pop-
ulations can donate mitochondria to BEAS2B epithelial
cells, as indicated by increased BEAS2B Mitotracker
Green fluorescence (Fig. 4) and decreased MSC Mito-
tracker Green fluorescence (Additional file 4: Figure
S3B) after co-culture. When visualized using live cell
confocal microscopy, mitochondria localized within MSC
microtubules or TNTs, tracked towards BEAS2B cells and
crossed the cell membrane border. In addition, individual
mitochondrion could be seen within endosomes (Fig. 4e,
white arrowhead) and microvesicles (Fig. 4e, f, white ar-
rows). Following co-culture with BM-MSCs, BEAS2B
Mitotracker Green MFI increased 15.9-fold (10.7–22.4,
n = 10). Similarly, BEAS2B Mitotracker Green MFI in-
creased 26.7-fold (12.1–44.6, n = 10) after co-culture
with LT-MSCs and increased 15.9-fold (12.7–25.2, n = 9)
after co-culture with BAL-MSCs (Fig. 4d). Mitochondrial
transfer was not observed when BEAS2B cells were co-
Fig. 3 BM-MSCs, LT-MSCs and BAL-MSCs donate cytoplasmic contents to BEAS2B epithelial cells via multiple mechanisms. Bone marrow-derived
mesenchymal stromal cells (BM-MSCs, a), lung tissue-derived mesenchymal stromal cells (LT-MSCs, b) and bronchoalveolar fluid-derived mesenchymal
stromal cells (BAL-MSCs, c) were co-cultured with BEAS2B epithelial cells and treated with either dynasore to inhibit endocytosis, cytochalasin D
to inhibit microtubule/TNT formation, carbenoxolone to inhibit all gap junction formation or GAP26 to inhibit connexin-43 gap junction
formation. Y axis represents this change in mean fluorescent intensity (MFI, %) relative to paired, uninhibited control. Horizontal line represents
median. Groups were compared using the Mann–Whitney U test. *p < 0.05 compared with baseline
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cultured with any MSC populations using a transwell
set-up (Fig. 4c). Additionally, we did not observe any
mitochondrial transfer from BEAS2B cells to any MSC
populations (Fig. 4b).
Mitochondrial transfer from BM-MSCs, LT-MSCs and
BAL-MSCs to BEAS2B epithelial cells is mediated by
contact-dependent and non-dependent mechanisms
Inhibiting endocytosis in BEAS2B cells resulted in a
15.8 % (14.6–31.2, p < 0.05, n = 7) decrease in transfer in
BM-MSC co-cultures (Fig. 5). Mitochondrial donation
was also decreased after endocytosis inhibition by 34.7 %
(32.3–37.4, p < 0.05, n = 7) in LT-MSCs and by 25.2 %
(20.0–30.3, p < 0.05, n = 7) in BAL-MSC co-cultures
(Fig. 5). Inhibiting microtubule/TNT formation reduced
mitochondrial transfer by 25.5 % (23.6–29.7, p < 0.05,
n = 7) in BM-MSC co-cultures. Transfer was reduced
by 13.8 % (12.4–16.2, p < 0.05, n = 7) in LT-MSC co-
cultures and by 11.0 % (10.0–30.3, p < 0.05, n = 7) in
BAL-MSC co-cultures. The non-specific inhibition of
gap junction formation reduced mitochondrial dona-
tion by 26.8 % (23.8–32.5, p < 0.05, n = 7) in BM-MSC
co-cultures and by 10.9 % (7.5–15.6, p < 0.05, n = 7) in
BAL-MSC co-cultures. Gap junction inhibition did
not reduce mitochondrial donation in LT-MSC co-
cultures. Finally, connexin-43 inhibition did not re-
duce mitochondrial transfer in any MSC-BEAS2B cell
co-culture (Fig. 5). When all inhibitory compounds
were added together we observed greater attenuation
of mitochondrial transfer (Fig. 5), suggesting synergy
Fig. 4 BM-MSCs, LT-MSCs and BAL-MSCs donate mitochondria to BEAS2B epithelial cells. Mitochondrial transfer between mesenchymal stromal
cells (MSCs) and BEAS2B bronchial epithelial cells was measured by flow cytometry and confocal microscopy. a Representative flow cytometry plot
of transfer after MSCs were labelled with Mitotracker Green and co-cultured with BEAS2B cells for 4 hours. Blue line represents co-cultured BEAS2B
cells, red line represents unstained control. b To assess whether epithelial cells were capable of donating mitochondrial to MSCs,
BEAS2B cells were labelled with Mitotracker Green and co-cultured with MSCs for 4 h. Blue line represents co-cultured MSCs, red
line represents unstained control. c Representative flow cytometry plot of transfer after MSCs were labelled with Mitotracker
Green and co-cultured with BEAS2B cells within a transwell configuration. d Grouped data of mitochondrial transfer by bone
marrow-derived (BM-MSCs), lung tissue-derived (LT-MSCs) and bronchoalveolar fluid-derived (BAL-MSCs) MSCs. Y axis represents
the fold-change increase in Mitotracker Green mean fluorescent intensity (MFI) of BEAS2B cells after co-culture with each respective
MSC population. Horizontal bars represent median. e–g Confocal microscopy images of mitochondrial transfer by BM-MSCs (e), LT-MSCs (f)
and BAL-MSCs (g). MSCs were pre-labelled with Mitotracker Green (green) and co-cultured with BEAS2B epithelial cells labelled with DiD (red).
Images are shown at 630× magnification with an oil immersion lens. White arrows point to microvesicles containing mitochondria, white
arrowhead points to an endocytosed MSC-derived mitochondria
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between microtubule/TNT, endocytosis and gap junc-
tion mediated mechanisms.
Discussion
MSCs exhibit therapeutic effects in multiple models of
acute and chronic lung epithelial injury and represent a
promising therapeutic approach for the treatment of
end-stage lung diseases including idiopathic pulmonary
fibrosis [39] and acute lung injury [40] in humans.
These studies have utilized MSCs isolated from tissue
sources such as the bone marrow, adipose and placenta.
Comparative studies have demonstrated that, irrespect-
ive of source, MSCs from any two tissues are strikingly
similar [41, 42]. Despite this, each population possesses
subtle nuances, specific to their source [30, 43], which
may confer additional benefit or efficiency in a thera-
peutic context. One of the mechanisms by which MSCs
support epithelial cell repair is thought to be via direct
transfer of cytoplasmic contents [9, 35], but the nature
of the transferred material, mechanisms of transfer, ef-
fects on target cells and effects of the tissue microenvir-
onment have yet to be fully defined. In this study, we
demonstrate that human MSCs isolated from bone
marrow, parenchymal lung tissue and BAL fluid donate
cytoplasmic contents and mitochondria to bronchial
epithelial cells. Transfer was rapid, uni-directional and
mediated by multiple mechanisms including microvesi-
cles, microtubules/TNTs and non-connexin-43 gap junc-
tions. Similar mechanisms contributed to mitochondrial
donation in BM-MSCs and BAL-MSCs, whereas microve-
sicles and microtubules/TNTs, but not gap junctions, con-
tributed to mitochondrial transfer by LT-MSCs. Inhibiting
these pathways did not completely prevent mitochondrial
donation, however, suggesting the existence of additional
mechanisms. These findings add to a growing body of lit-
erature which demonstrates MSCs isolated from different
sources are similar but exhibit subtle differences which
may be reflective of adaption to a specific tissue. Our data
provide further support to the idea that human lung-
derived mesenchymal populations contribute to tissue
Fig. 5 BM-MSCs, LT-MSCs and BAL-MSCs donate mitochondria to BEAS2B epithelial cells. Bone marrow-derived mesenchymal stromal cells
(BM-MSCs, a), lung tissue-derived mesenchymal stromal cells (LT-MSCs, b) and bronchoalveolar fluid-derived mesenchymal stromal cells (BAL-MSCs, c)
were cultured with either dynasore to inhibit endocytosis, cytochalasin D to inhibit microtubule/nanotube formation, carbenoxolone to inhibit
all gap junction formation or GAP26 to inhibit connexin-43 gap junction formation. Y axis represents this change in mean fluorescent intensity
(MFI, %) relative to a paired, uninhibited control. Horizontal line represents median. Groups were compared using the Mann–Whitney U test.
*p < 0.05 compared with baseline




Age at transplantation (years) 38.75 (30.0–56.0)
Male sex 10 (71.4)
Donor age (years) 30 (28–54)
Male donor sex 10 (71.4)
Time post transplant (years) 2.78 (0.27–4.48)
Pre-transplant diagnosis
Cystic fibrosis 6 (42.8)
Chronic obstructive pulmonary disease 4 (28.5)






Data presented as median (interquartile range) or n (%)
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homeostasis and repair through direct interaction with
epithelial cell populations.
BAL-MSCs are a unique population of transplant
donor-derived cells that are generally only recoverable
from lung allografts [29, 30]. Their absence from healthy
individuals and correlation with disease has led to the
suggestion that BAL-MSCs are either a causal factor for
lung disease [44, 45] or an epiphenomenon. We have
previously postulated that BAL-MSCs are derived from
an in-tissue source which has mobilized into the alveolar
space to provide support for injured epithelial cells [30].
This is supported by previous studies demonstrating that
BAL-MSCs administered to mice preferentially engraft
in close proximity to alveolar progenitor cells and do-
nate keratinocyte growth factor via connexin-43 gap
junctions [35]. Our findings expand on this by demon-
strating that cytoplasmic content is transferred from hu-
man LT-MSCs and BAL-MSCs to human bronchial
epithelial cells and by identifying a capacity for mito-
chondrial donation. Unlike previous studies, we were
unable to identify a role of connexin-43 in the transfer
of cytoplasmic content or mitochondria. These findings
provide a foundation for future investigations into the
reparative capacity of BAL-MSCs and LT-MSCs.
Although it is now clear that LT-MSCs and BAL-
MSCs transfer cytoplasmic material to the lung epithe-
lium, the composition of transferred material remains to
be characterized. We hypothesize that LT-MSCs and
BAL-MSCs transfer material analogous to that produced
by BM-MSCs. While this material remains incompletely
defined, it is known to include growth factors [26, 46],
immuno-modulatory molecules [16, 47], transcription
factors [12] and micro-RNAs [11, 14]. Human BAL-
MSCs are thought to transfer keratinocyte growth factor
to murine type 2 alveolar epithelial cells, in vivo [35].
Additionally, murine LT-MSCs have been demonstrated
to produce fibroblast growth factor-10 and hepatocyte
growth factor which drives the differentiation of epithe-
lial progenitor cells into complex airway and alveolar
structures, in vitro [2]. Together, these findings support
the notion that the role of MSCs within tissue is to pro-
vide support, be it by the production of paracrine factors
or mitochondrial donation to the surrounding parenchy-
mal populations.
Our data suggest that human BM-MSCs and BAL-
MSCs employ a non-connexin-43 gap junction in the
transfer of cytoplasmic content and mitochondria to
bronchial epithelial cells. This finding was surprising as
connexin-43 has previously been demonstrated to medi-
ate both cytoplasmic and mitochondrial transfer from
BM-MSCs to alveolar epithelial cells [9]. Together, these
findings suggest MSCs utilize gap junctions in a region-
specific manner. To date, no other connexins have been
implicated in the transfer of cytoplasmic content or
mitochondria. The most logical alternative candidate is
connexin-26 which is expressed by basal cells [48]. Not-
ably, basal cells serve as a progenitor cell for the bron-
chial epithelium [49] and interaction between basal cells
and local MSCs would fit with the developing narrative
of the pulmonary stem cell niche.
There are several limitations to this study. Firstly, our
study used a human bronchial epithelial cell line which
may limit the generalisability of our findings to primary
cells. This may explain why we were unable to demonstrate
a role for connexin-43 in cytoplasmic or mitochondrial do-
nation. However, healthy human lung epithelium is difficult
to obtain and requires a heavily supplemented growth
medium, which in itself can lead to artefacts. Secondly, the
isolation and ex-vivo expansion of MSCs can lead to func-
tional alterations, including their interaction with lung epi-
thelial cells [2]. Therefore, we used MSCs at the lowest
passage feasibly possible and passage-matched all samples.
Conclusion
LT-MSCs and BAL-MSCs share a similar capacity for cyto-
plasmic and mitochondrial transfer to bronchial epithelial
cells. Transfer is rapid, ubiquitous and unidirectional from
MSCs to the epithelium. These findings offer novel insight
into the potential role of lung MSCs in organ homeostasis
and repair.
Additional files
Additional file 1: Figure S1. Showing the gating strategy for measuring
BEAS2B Calcein AM fluorescence after co-culture. MFI of Calcein AM within
BEAS2B cells was determined by flow cytometry. (a) Forward/side scatter
gating was used to exclude debris. (b) BEAS2B epithelial cells were then
selected based on DiD fluorescence. (c) Doublets were then eliminated
using forward scatter—width and height. (d) A fluorescence minus one
control (red line) was used to distinguish positive Calcein AM and negative
BEAS2B cells. (TIF 481 kb)
Additional file 2: Figure S2. Showing the gating strategy for measuring
BEAS2B Mitotracker Green fluorescence. MFI of Mitotracker Green within
BEAS2B cells was determined by flow cytometry. (a) Forward/side
scatter gating was used to exclude debris. (b) BEAS2B epithelial cells
were then selected based on DiD fluorescence. (c) Doublets were then
eliminated using forward scatter—width and height. (d) A fluorescence
minus one control (red line) was used to distinguish positive Mitotracker
Green and negative BEAS2B cells. (TIF 461 kb)
Additional file 3: Table S1. Presenting supplementary methods.
(DOCX 12 kb)
Additional file 4: Figure S3. Showing that MSC Mitotracker Green
fluorescence decreases after co-culture with BEAS2B epithelial cells.
The change in mesenchymal stromal cell fluorescence (a Calcein AM,
b Mitotracker Green) after co-culture with BEAS2B epithelial cells. Dotted
horizontal line represents baseline calculated as the MFI of MSC grown in
homogenous cultures. Solid horizontal line represents median. (TIF 20 kb)
Abbreviations
BAL, bronchoalveolar lavage; BAL-MSC, bronchoalveolar lavage-derived
mesenchymal stromal cell; BEGM, basal epithelial growth medium; BM-MSC,
bone marrow-derived mesenchymal stromal cell; DMEM, Dulbecco’s modified
Eagle medium; HSC, haematopoietic stem cell; LT-MSC, lung tissue-derived
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